X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DR. REDDYS LAB TTK HEALTHCARE/
DR. REDDYS LAB
 
P/E (TTM) x 29.1 27.3 106.6% View Chart
P/BV x 5.4 2.8 190.6% View Chart
Dividend Yield % 0.5 1.0 53.8%  

Financials

 TTK HEALTHCARE   DR. REDDYS LAB
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
DR. REDDYS LAB
Mar-16
TTK HEALTHCARE/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs6634,383 15.1%   
Low Rs3992,750 14.5%   
Sales per share (Unadj.) Rs535.6920.1 58.2%  
Earnings per share (Unadj.) Rs15.9126.1 12.6%  
Cash flow per share (Unadj.) Rs20.0183.0 10.9%  
Dividends per share (Unadj.) Rs4.0020.00 20.0%  
Dividend yield (eoy) %0.80.6 134.3%  
Book value per share (Unadj.) Rs137.6685.8 20.1%  
Shares outstanding (eoy) m7.77170.61 4.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.03.9 25.6%   
Avg P/E ratio x33.328.3 117.8%  
P/CF ratio (eoy) x26.519.5 136.1%  
Price / Book Value ratio x3.95.2 74.2%  
Dividend payout %25.115.9 158.2%   
Avg Mkt Cap Rs m4,127608,481 0.7%   
No. of employees `0001.721.7 7.9%   
Total wages/salary Rs m60731,874 1.9%   
Avg. sales/employee Rs Th2,436.77,244.4 33.6%   
Avg. wages/employee Rs Th355.21,470.9 24.1%   
Avg. net profit/employee Rs Th72.5992.8 7.3%   
INCOME DATA
Net Sales Rs m4,162156,978 2.7%  
Other income Rs m612,693 2.3%   
Total revenues Rs m4,223159,671 2.6%   
Gross profit Rs m19734,587 0.6%  
Depreciation Rs m329,705 0.3%   
Interest Rs m30824 3.6%   
Profit before tax Rs m19726,751 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m735,237 1.4%   
Profit after tax Rs m12421,514 0.6%  
Gross profit margin %4.722.0 21.5%  
Effective tax rate %37.019.6 189.1%   
Net profit margin %3.013.7 21.7%  
BALANCE SHEET DATA
Current assets Rs m1,629118,201 1.4%   
Current liabilities Rs m1,05868,368 1.5%   
Net working cap to sales %13.731.7 43.2%  
Current ratio x1.51.7 89.1%  
Inventory Days Days3060 49.6%  
Debtors Days Days3497 34.7%  
Net fixed assets Rs m55672,265 0.8%   
Share capital Rs m78853 9.1%   
"Free" reserves Rs m878111,548 0.8%   
Net worth Rs m1,069117,009 0.9%   
Long term debt Rs m15910,690 1.5%   
Total assets Rs m2,399200,104 1.2%  
Interest coverage x7.633.5 22.6%   
Debt to equity ratio x0.10.1 162.4%  
Sales to assets ratio x1.70.8 221.1%   
Return on assets %6.411.2 57.4%  
Return on equity %11.618.4 63.0%  
Return on capital %18.521.6 85.5%  
Exports to sales %0.846.3 1.7%   
Imports to sales %1.49.0 15.7%   
Exports (fob) Rs m3372,618 0.0%   
Imports (cif) Rs m5814,050 0.4%   
Fx inflow Rs m3375,405 0.0%   
Fx outflow Rs m6327,115 0.2%   
Net fx Rs m-3048,290 -0.1%   
CASH FLOW
From Operations Rs m12740,476 0.3%  
From Investments Rs m-146-19,421 0.8%  
From Financial Activity Rs m22-17,009 -0.1%  
Net Cashflow Rs m34,046 0.1%  

Share Holding

Indian Promoters % 65.4 25.5 256.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 5.4 68.5%  
FIIs % 5.2 35.3 14.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 25.8 15.3 168.6%  
Shareholders   12,723 75,885 16.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SANOFI INDIA  ABBOTT INDIA  PLETHICO PHARMA  CIPLA  TORRENT PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 18, 2017 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS